sulfadoxine has been researched along with Pneumococcal Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chandramohan, D; Compaore, YD; Frédéric, N; Greenwood, B; Hema-Ouangraoua, S; Kabore, NF; Kuepfer, I; Ouedraogo, JB; Tinto, H; Yerbanga, RS; Zongo, I | 1 |
| Church, DL; Kellner, JD; MacDonald, J; Vanderkooi, OG; Zucol, F | 1 |
2 other study(ies) available for sulfadoxine and Pneumococcal Infections
| Article | Year |
|---|---|
Serotype Profile of Nasopharyngeal Isolates of
Topics: Amodiaquine; Anti-Bacterial Agents; Antimalarials; Azithromycin; Burkina Faso; Carrier State; Chemoprevention; Child, Preschool; Drug Combinations; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Humans; Infant; Malaria; Male; Mass Drug Administration; Nasopharynx; Pneumococcal Infections; Pneumococcal Vaccines; Pyrimethamine; Seasons; Serogroup; Streptococcus pneumoniae; Sulfadoxine | 2020 |
Community-based outbreaks in vulnerable populations of invasive infections caused by Streptococcus pneumoniae serotypes 5 and 8 in Calgary, Canada.
Topics: Alberta; Disease Outbreaks; Drug Combinations; Humans; Microbial Sensitivity Tests; Pneumococcal Infections; Streptococcus pneumoniae; Sulfadoxine; Trimethoprim | 2011 |